Cooper Companies, Inc. (The) (NYSE:COO) traded down 5.8% during trading on Friday . The company traded as low as $234.62 and last traded at $236.18, with a volume of 1,026,728 shares trading hands. The stock had previously closed at $250.83.

A number of equities research analysts recently commented on the stock. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies, Inc. (The) in a research report on Friday, July 21st. Piper Jaffray Companies increased their target price on shares of Cooper Companies, Inc. (The) to $265.00 and gave the company an “overweight” rating in a research report on Wednesday, July 19th. BidaskClub cut shares of Cooper Companies, Inc. (The) from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. Cleveland Research reissued a “buy” rating on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, August 22nd. Finally, Zacks Investment Research raised shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $277.00 target price for the company in a research report on Tuesday, August 22nd. Five equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $245.89.

The firm has a market cap of $11.54 billion, a PE ratio of 35.41 and a beta of 0.59. The firm has a 50 day moving average price of $246.43 and a 200-day moving average price of $221.27.

Cooper Companies, Inc. (The) (NYSE:COO) last released its quarterly earnings results on Thursday, August 31st. The medical device company reported $2.64 EPS for the quarter, beating the consensus estimate of $2.58 by $0.06. The firm had revenue of $556 million during the quarter, compared to the consensus estimate of $552.32 million. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.39%. Cooper Companies, Inc. (The)’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.30 EPS. Equities research analysts forecast that Cooper Companies, Inc. will post $9.64 EPS for the current fiscal year.

The company also recently disclosed a semiannual dividend, which was paid on Monday, August 7th. Shareholders of record on Friday, July 21st were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Wednesday, July 19th. This represents a yield of 0.02%. Cooper Companies, Inc. (The)’s payout ratio is currently 0.86%.

In other Cooper Companies, Inc. (The) news, COO Daniel G. Mcbride sold 6,000 shares of the company’s stock in a transaction on Wednesday, June 21st. The shares were sold at an average price of $244.23, for a total transaction of $1,465,380.00. Following the completion of the transaction, the chief operating officer now owns 34,395 shares in the company, valued at approximately $8,400,290.85. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Paul L. Remmell sold 9,294 shares of the company’s stock in a transaction on Friday, July 14th. The stock was sold at an average price of $248.46, for a total transaction of $2,309,187.24. Following the transaction, the chief executive officer now owns 6,186 shares of the company’s stock, valued at approximately $1,536,973.56. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 67,331 shares of company stock valued at $16,400,454. 1.60% of the stock is owned by insiders.

Several institutional investors have recently bought and sold shares of the company. Lord Abbett & CO. LLC boosted its position in Cooper Companies, Inc. (The) by 2.1% in the second quarter. Lord Abbett & CO. LLC now owns 405,831 shares of the medical device company’s stock worth $97,164,000 after buying an additional 8,316 shares during the period. Sentry Investment Management LLC boosted its position in Cooper Companies, Inc. (The) by 0.7% in the second quarter. Sentry Investment Management LLC now owns 2,801 shares of the medical device company’s stock worth $671,000 after buying an additional 19 shares during the period. Toronto Dominion Bank boosted its position in Cooper Companies, Inc. (The) by 25.3% in the second quarter. Toronto Dominion Bank now owns 16,552 shares of the medical device company’s stock worth $3,963,000 after buying an additional 3,344 shares during the period. Advisory Services Network LLC boosted its position in Cooper Companies, Inc. (The) by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after buying an additional 107 shares during the period. Finally, Dynamic Technology Lab Private Ltd bought a new position in Cooper Companies, Inc. (The) during the second quarter worth $423,000. 96.09% of the stock is currently owned by institutional investors and hedge funds.

WARNING: This piece was originally published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2017/09/03/cooper-companies-inc-the-coo-stock-price-down-5-8.html.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.